TELA Bio
TELA
58 hedge funds and large institutions have $117M invested in TELA Bio in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 20 reducing their positions, and 10 closing their positions.
1,129% more call options, than puts
Call options by funds: $86K | Put options by funds: $7K
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
0% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 20
2.04% less ownership
Funds ownership: 85.96% → 83.92% (-2%)
3% less funds holding
Funds holding: 60 → 58 (-2)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
16% less capital invested
Capital invested by funds: $139M → $117M (-$22.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$4.41M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.44M |
| 3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$1.31M |
| 4 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
+$1.28M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$474K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$4.49M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.42M |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$2.25M |
| 4 |
Morgan Stanley
New York
|
-$844K |
| 5 |
KSCM
Kamunting Street Capital Management
Miami Beach,
Florida
|
-$633K |
TELA Hedge Fund Activity: Q1 2024 in Review
58 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2024, worth a combined $117M — down 16% from $139M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TELA and 9 opened new positions — a net loss of 1 holder — while 20 trimmed existing stakes and 20 added.
The largest buyer was Velan Capital Investment Management, adding an estimated $4.41M. The largest seller was Pentwater Capital Management, cutting an estimated $4.49M.
- 58 institutional investors held TELA Bio (TELA) as of Q1 2024, down from 60 in Q4 2023.
- Funds reported $117M of TELA Bio stock for Q1 2024, down 16% quarter-over-quarter.
- 9 funds opened new TELA Bio positions in Q1 2024 and 10 closed out, a net change of -1 holder.
- The largest TELA Bio buyer in Q1 2024 was Velan Capital Investment Management, an estimated $4.41M added.
- The largest TELA Bio seller in Q1 2024 was Pentwater Capital Management, an estimated $4.49M sold.
Based on aggregated 13F filings for Q1 2024.